Back to Search

PETER SCARDINO, MD

MD

Urology Physician

NPI: 1427035856Individual

Specialties, Licenses & Credentials

Urology PhysicianPrimary

Urology

Code: 208800000X

210290(NY)

Research & Publications (20)

Focal therapy for prostate cancer: analysis by an international panel.
PMID 19095123·Urology·2008
8-other
The functional and structural consequences of cavernous nerve injury are ameliorated by sildenafil citrate.
PMID 18331274·J Sex Med·2008
7-preclinical
Update: NCCN prostate cancer Clinical Practice Guidelines.
PMID 16280109·J Natl Compr Canc Netw·2005
8-other
The Gordon Wilson Lecture. Natural history and treatment of early stage prostate cancer.
PMID 10881343·Trans Am Clin Climatol Assoc·2000
6-review
The COMPARE Registry: design and baseline patterns of care for men with biochemical failure after definitive treatment of localized prostate cancer.
PMID 19589569·Urology·2010
8-other
Focal treatment or observation of prostate cancer: pretreatment accuracy of transrectal ultrasound biopsy and T2-weighted MRI.
PMID 19643467·Urology·2010
8-other
Nomograms for staging, prognosis, and predicting treatment outcomes.
PMID 19544538·Cancer·2009
6-review
Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era.
PMID 19636023·J Clin Oncol·2009
4-observational
Peter Lester Scardino--a genitourinary surgeon in third generation of the specialty: part 2.
PMID 19394488·Urology·2009
8-other
Focal therapy for prostate cancer.
PMID 19352389·Nat Rev Urol·2009
8-other
The 2008 European School of Oncology inside track conference, "predictive modeling in prostate cancer".
PMID 19544554·Cancer·2009
8-other
Prostate-specific antigen velocity for early detection of prostate cancer: result from a large, representative, population-based cohort.
PMID 19682790·Eur Urol·2009
8-other
Prognostic value of Akt-1 in human prostate cancer: a computerized quantitative assessment with quantum dot technology.
PMID 19417030·Clin Cancer Res·2009
8-other
Peter Lester Scardino--a genitourinary surgeon in third generation of the specialty: part 1.
PMID 19394487·Urology·2009
8-other
Prediction of prostate cancer recurrence using magnetic resonance imaging and molecular profiles.
PMID 19435838·Clin Cancer Res·2009
8-other
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate.
PMID 19396168·Nat Genet·2009
7-preclinical
Impact of ethnicity on surgical margins at radical prostatectomy.
PMID 19389008·BJU Int·2009
8-other
Prostate size is associated with surgical difficulty but not functional outcome at 1 year after radical prostatectomy.
PMID 19616260·J Urol·2009
8-other
Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomy.
PMID 19506163·J Clin Oncol·2009
8-other
Safety in surgery: the checklist.
PMID 19424167·Nat Rev Urol·2009
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
1275 YORK AVE
NEW YORK, NY 10021

Location

Practice Location

1275 YORK AVE, NEW YORK, NY
(212) 639-2000

Quick Facts

NPI
1427035856
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile